Danny Sullivan

Longevity investment bulletin: Mitobridge, Fractyl Health, Insilico Medicine, Huma Therapeutics, Rubedo Life Sciences and more.

The latest longevity investment news and updates from our investment news desk. Featuring: CARMAT, Longeveron, NeuroSense and Capsida.

EMulate Therapeutics uses magnetic field technology to emulate drug effects in humans and animal models without using chemicals.

Recent clinical studies of longevity supplement spermidine show potential in multiple conditions, from fatty liver disease to heart disease.

Biolytica CEO on the importance of using combined health data and AI in longevity to enable personalised and preventive health to flourish.

Regenerative Medicine Foundation highlights the need for patient advocacy in longevity and calls for treatments to be made available to all.

Top investor talks longevity investment, optimism on SPAC deal, and light at the end of the tunnel for the biotech market.

Investment arm of world’s most valuable company leads new $35 million investment in AI drug discovery firm Insilico Medicine.

First Longevity aims to accelerate growth in the longevity sector with dedicated platform for accredited investors.

Longevity company Vitalunga to develop mitophagy-activating drugs that rejuvenate cells, and extend lifespan and healthspan in worm models.

Morphoceuticals has “zero doubt” that regeneration research conducted in frogs can be recreated in humans – it’s just a matter of time.

Juvenescence-backed MDI Therapeutics gears up with $9m for clinical trials of serpin-based fibrosis therapy.

Longevity biotech focused venture capital firm moves into the decentralized Web3 ecosystem with new partnership.

Rather than study animals that age quickly, Prof Steven Austad believes animals that age slowly may hold the answers to human longevity.

Scottish AI software company Aveni today announced the appointment of Elizabeth Gooch, MBE, as the company’s Chief Revenue Officer. Hot… | Technology | Appointments | Technology | Edinburgh | Startups |